Jefferies Group’s MoonLake Immunotherapeutics MLTX Stock Holding History

Jefferies Group’s Portfolio MLTX Stock Details MLTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$525K	Buy
2022 Q1	–	Sell
2021 Q4	$774K	Buy